Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies
- PMID: 33296566
- PMCID: PMC7745168
- DOI: 10.1056/NEJMe2032071
Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies
Comment on
-
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21. N Engl J Med. 2020. PMID: 33085857 Free PMC article. Clinical Trial.
Similar articles
-
[COVID-19: Still a place for tocilizumab?].Rev Med Interne. 2021 Feb;42(2):73-78. doi: 10.1016/j.revmed.2020.11.016. Epub 2020 Nov 27. Rev Med Interne. 2021. PMID: 33288230 Free PMC article. Review. French. No abstract available.
-
Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):30896-30897. doi: 10.1073/pnas.2009961117. Epub 2020 Nov 17. Proc Natl Acad Sci U S A. 2020. PMID: 33203671 Free PMC article. No abstract available.
-
Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30027-30028. doi: 10.1073/pnas.2011616117. Epub 2020 Nov 12. Proc Natl Acad Sci U S A. 2020. PMID: 33184171 Free PMC article. No abstract available.
-
Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab.Adv Respir Med. 2020;88(5):468-469. doi: 10.5603/ARM.a2020.0123. Adv Respir Med. 2020. PMID: 33169824 No abstract available.
-
Tocilizumab: From Rheumatic Diseases to COVID-19.Curr Pharm Des. 2021;27(13):1597-1607. doi: 10.2174/1381612827666210311141512. Curr Pharm Des. 2021. PMID: 33719967 Review.
Cited by
-
Correlation of Patient Profiles and Biomarkers with Outcomes in Covid-19 Icu Patients: A Retrospective Analysis.Rom J Anaesth Intensive Care. 2022 Dec 29;28(2):71-79. doi: 10.2478/rjaic-2021-0012. eCollection 2021 Dec. Rom J Anaesth Intensive Care. 2022. PMID: 36844114 Free PMC article.
-
Case Report: Takotsubo Syndrome Associated With Novel Coronavirus Disease 2019.Front Cardiovasc Med. 2021 Feb 22;8:614562. doi: 10.3389/fcvm.2021.614562. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33693034 Free PMC article.
-
Intensive Care Patients from the First COVID-19 Wave: One-Year Survival after Tocilizumab Treatment.J Pers Med. 2021 Nov 21;11(11):1234. doi: 10.3390/jpm11111234. J Pers Med. 2021. PMID: 34834586 Free PMC article.
-
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?Inflammopharmacology. 2023 Apr;31(2):633-651. doi: 10.1007/s10787-023-01160-w. Epub 2023 Feb 27. Inflammopharmacology. 2023. PMID: 36849853 Free PMC article. Review.
-
Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19.Acute Crit Care. 2023 Feb;38(1):41-48. doi: 10.4266/acc.2022.01235. Epub 2023 Feb 22. Acute Crit Care. 2023. PMID: 36935533 Free PMC article.
References
-
- Roche’s Actemra fails to meet Phase III goals in Covid-19 patients. Cision. July 29 2020 (https://www.clinicaltrialsarena.com/news/roche-actemra-covid-data/).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources